Agnieszka K. Czopik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Agnieszka K. Czopik has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Holger K. Eltzschig
The University of Texas Health Science Center at Houston
3 shared publications - Xiaoyi Yuan
The University of Texas Health Science Center Houston
3 shared publications - Anil K. Sood
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publications - Hongfang Liu
Department of Quantitative and Systems Health Sciences, University of Texas at Austin Dell Medical School, Austin, TX 78712, USA
2 shared publications - Jinlian Wang
Department of Health Data Science and Artificial Intelligence, McWilliams School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas
2 shared publications - Katherine Figarella
Department of Neurophysiology, Institute of Physiology, University of Tuebingen, Tuebingen, Germany
2 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (5) , 1204-1224
Hypoxia-inducible Factor 1α–dependent Induction of Alveolar miR-147b and Direct Targeting of Viral RNA in SARS-CoV-2–associated Acute Respiratory Distress Syndrome
Background: Acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality during viral pneumonia, including SARS-CoV-2 infections. Nevertheless, most patients with SARS-CoV-2 infections recover seamlessly without developing ARDS, suggesting the existence of endogenous pathways to protect the lungs. Since microRNAs (miRNAs) can regulate endogenous molecular pathways involved in lung protection, the authors hypothesized that alveolar miRNAs could function to dampen SARS-CoV-2–associated lung injury. Methods: Screening studies in human alveolar epithelial cells and SARS-CoV-2–infected mice were performed to identify miRNAs induced during infection. Candidate miRNAs were confirmed via reverse-transcription quantitative polymerase chain reaction. The role of hypoxia-inducible factor 1α in regulating miRNA expression was examined in molecular studies. Loss- and gain-of-function approaches in a murine SARS-CoV-2-associated ARDS model were used to assess the physiologic relevance of miRNA. Viral sequence analyses and site-directed mutagenesis were used to determine direct miRNA–viral RNA interactions. Results: Screening studies identified miR-147b (hsa-miR-147b-3p or mmu-miR-147-3p) as the leading candidate during infection of human alveolar epithelia or mice with SARS-CoV-2. Functional and molecular studies implicate hypoxia-inducible factor 1α in miR-147b induction during alveolar injury or SARS-CoV-2 infection. Studies in mice with induced deletion of miR-147b in alveolar epithelia ( miR147 fl/fl Sftpc-CreER T2 (SPC-CreER) mice) or nanoparticle-mediated miR-147b overexpression revealed a protective role of alveolar-expressed miR-147b during murine SARS-CoV-2–associated ARDS. Moreover, the authors identified the Open Reading Frame 8 ( ORF8 ) region within the SARS-CoV-2 template strand as a direct target of miR-147b, with an ORF8 silent mutation of the SARS-CoV-2 miR-147b–binding site abolishing the observed protection in vitro and in vivo . Conclusions: Alveolar epithelial cell–derived miR-147b serves as an endogenous lung protective miRNA against SARS-CoV-2–associated ARDS by directly targeting virus-encoded RNA, revealing a previously unrecognized antiviral and lung-protective mechanism.
- 4 August 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 145 (5) , 1204-1224
Open AccessHypoxia-inducible Factor 1α–dependent Induction of Alveolar miR-147b and Direct Targeting of Viral RNA in SARS-CoV-2–associated Acute Respiratory Distress Syndrome
Background: Acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality during viral pneumonia, including SARS-CoV-2 infections. Nevertheless, most patients with SARS-CoV-2 infections recover seamlessly without developing ARDS, suggesting the existence of endogenous pathways to protect the lungs. Since microRNAs (miRNAs) can regulate endogenous molecular pathways involved in lung protection, the authors hypothesized that alveolar miRNAs could function to dampen SARS-CoV-2–associated lung injury. Methods: Screening studies in human alveolar epithelial cells and SARS-CoV-2–infected mice were performed to identify miRNAs induced during infection. Candidate miRNAs were confirmed via reverse-transcription quantitative polymerase chain reaction. The role of hypoxia-inducible factor 1α in regulating miRNA expression was examined in molecular studies. Loss- and gain-of-function approaches in a murine SARS-CoV-2-associated ARDS model were used to assess the physiologic relevance of miRNA. Viral sequence analyses and site-directed mutagenesis were used to determine direct miRNA–viral RNA interactions. Results: Screening studies identified miR-147b (hsa-miR-147b-3p or mmu-miR-147-3p) as the leading candidate during infection of human alveolar epithelia or mice with SARS-CoV-2. Functional and molecular studies implicate hypoxia-inducible factor 1α in miR-147b induction during alveolar injury or SARS-CoV-2 infection. Studies in mice with induced deletion of miR-147b in alveolar epithelia ( miR147 fl/fl Sftpc-CreER T2 (SPC-CreER) mice) or nanoparticle-mediated miR-147b overexpression revealed a protective role of alveolar-expressed miR-147b during murine SARS-CoV-2–associated ARDS. Moreover, the authors identified the Open Reading Frame 8 ( ORF8 ) region within the SARS-CoV-2 template strand as a direct target of miR-147b, with an ORF8 silent mutation of the SARS-CoV-2 miR-147b–binding site abolishing the observed protection in vitro and in vivo . Conclusions: Alveolar epithelial cell–derived miR-147b serves as an endogenous lung protective miRNA against SARS-CoV-2–associated ARDS by directly targeting virus-encoded RNA, revealing a previously unrecognized antiviral and lung-protective mechanism.
- Open Access
- 16 September 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (20)
miR147 promotes mucosal integrity and healing in intestinal inflammation
The intestinal mucosal epithelium forms a barrier between luminal contents and the body. MicroRNAs (miRNAs) regulate mucosal homeostasis by controlling inflammatory responses and structural integrity. Here, we discovered a protective role for miR147 in intestinal inflammation using a miR147tdTomato reporter mouse. miR147 was enriched in the intestines, with the highest expression in the colonic epithelial cells at the luminal surface, with prominent expression in differentiated enterocytes. Mice with general or intestinal epithelial deletion of miR147 showed increased intestinal inflammation and diminished mucosal healing during colitis. RNA sequencing of miR147-deficient cells showed dysregulated immune signaling, with upregulated proinflammatory cytokine pathways and reduced type I interferon responses and revealed Ndufa4 as a likely miR147 target. Ndufa4, a mitochondrial protein regulating energy metabolism and inflammation, was elevated at the crypt base, inversely correlating with miR147. Mice lacking the miR147 binding site in Ndufa4’s 3′-UTR phenocopied miR147-deficient mice during colitis. Spatial and single-cell transcriptomic analyses in murine and human colons showed mutually exclusive miR147 and Ndufa4 expression, consistent with a regulatory relationship in epithelial differentiation and metabolism. These findings underscore miR147’s role in intestinal homeostasis and mucosal healing, suggesting it as a therapeutic target for inflammatory bowel disease.
- 16 September 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (20)
Open AccessmiR147 promotes mucosal integrity and healing in intestinal inflammation
The intestinal mucosal epithelium forms a barrier between luminal contents and the body. MicroRNAs (miRNAs) regulate mucosal homeostasis by controlling inflammatory responses and structural integrity. Here, we discovered a protective role for miR147 in intestinal inflammation using a miR147tdTomato reporter mouse. miR147 was enriched in the intestines, with the highest expression in the colonic epithelial cells at the luminal surface, with prominent expression in differentiated enterocytes. Mice with general or intestinal epithelial deletion of miR147 showed increased intestinal inflammation and diminished mucosal healing during colitis. RNA sequencing of miR147-deficient cells showed dysregulated immune signaling, with upregulated proinflammatory cytokine pathways and reduced type I interferon responses and revealed Ndufa4 as a likely miR147 target. Ndufa4, a mitochondrial protein regulating energy metabolism and inflammation, was elevated at the crypt base, inversely correlating with miR147. Mice lacking the miR147 binding site in Ndufa4’s 3′-UTR phenocopied miR147-deficient mice during colitis. Spatial and single-cell transcriptomic analyses in murine and human colons showed mutually exclusive miR147 and Ndufa4 expression, consistent with a regulatory relationship in epithelial differentiation and metabolism. These findings underscore miR147’s role in intestinal homeostasis and mucosal healing, suggesting it as a therapeutic target for inflammatory bowel disease.
- Open Access
- 14 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4+ T cells during intestinal inflammation and alter the functional responses of T cells via regulation of microRNAs. Our assays reveal markedly increased T cell-intrinsic hypoxia and stabilization of HIF protein during experimental colitis. microRNA screen in primary CD4+ T cells points us towards miR-29a and our subsequent studies identify a selective role for HIF-2α in CD4-cell-intrinsic induction of miR-29a during hypoxia. Mice with T cell-intrinsic HIF-2α deletion display elevated T-bet (target of miR-29a) levels and exacerbated intestinal inflammation. Mice with miR-29a deficiency in T cells show enhanced intestinal inflammation. T cell-intrinsic overexpression of HIF-2α or delivery of miR-29a mimetic dampen TH1-driven colitis. In this work, we show a previously unrecognized function for hypoxia-dependent induction of miR-29a in attenuating TH1-mediated inflammation.
- 14 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessHIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4+ T cells during intestinal inflammation and alter the functional responses of T cells via regulation of microRNAs. Our assays reveal markedly increased T cell-intrinsic hypoxia and stabilization of HIF protein during experimental colitis. microRNA screen in primary CD4+ T cells points us towards miR-29a and our subsequent studies identify a selective role for HIF-2α in CD4-cell-intrinsic induction of miR-29a during hypoxia. Mice with T cell-intrinsic HIF-2α deletion display elevated T-bet (target of miR-29a) levels and exacerbated intestinal inflammation. Mice with miR-29a deficiency in T cells show enhanced intestinal inflammation. T cell-intrinsic overexpression of HIF-2α or delivery of miR-29a mimetic dampen TH1-driven colitis. In this work, we show a previously unrecognized function for hypoxia-dependent induction of miR-29a in attenuating TH1-mediated inflammation.